fruquintinib
FDA Approves Fruzaqla in Refractory Metastatic Colorectal Cancer
The FDA approved fruquintinib (Fruzaqla, Takeda) for some previously treated adults with metastatic colorectal ...
NOVEMBER 15, 2023

Load more